{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:53:20Z","timestamp":1783130000765,"version":"3.54.6"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ygyno.2016.09.011","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T17:31:30Z","timestamp":1474133490000},"page":"552-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Patterns of recurrence and survival in neuroendocrine cervical cancer"],"prefix":"10.1016","volume":"143","author":[{"given":"Shane R.","family":"Stecklein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Jhingran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Burzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetha","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann H.","family":"Klopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Eifel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0810-2648","authenticated-orcid":false,"given":"Michael","family":"Frumovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.09.011_bb0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/14737140.2015.1047767","article-title":"Challenges in the diagnosis and management of cervical neuroendocrine carcinoma","volume":"15","author":"Burzawa","year":"2015","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0010","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00001813-199908000-00003","article-title":"Phase II trial of neoadjuvant chemotherapy in early-stage small cell cervical cancer","volume":"10","author":"Chang","year":"1999","journal-title":"Anti-Cancer Drugs"},{"issue":"347","key":"10.1016\/j.ygyno.2016.09.011_bb0015","first-page":"e1","article-title":"Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients","volume":"203","author":"Cohen","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0020","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ygyno.2013.02.025","article-title":"Diagnosis, clinicopathologic features, treatment, and prognosis of small cell carcinoma of the uterine cervix; Kansai Clinical Oncology Group\/intergroup study in Japan","volume":"129","author":"Kuji","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/annonc\/mdm465","article-title":"Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study","volume":"19","author":"Lee","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3892\/ol.2011.439","article-title":"Prognostic factors and treatment comparison in early-stage small cell carcinoma of the uterine cervix","volume":"3","author":"Tian","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2003.12.027","article-title":"Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence","volume":"93","author":"Viswanathan","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document","volume":"122","author":"Gardner","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0045","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1097\/IGC.0000000000000262","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix","volume":"24","author":"Satoh","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2016.09.011_bb0050","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2002.12.071","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104","volume":"20","author":"Takada","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0055","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1200\/JCO.2005.02.9793","article-title":"Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer","volume":"24","author":"De Ruysscher","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/annonc\/mdj094","article-title":"Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer","volume":"17","author":"De Ruysscher","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0065","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1200\/JCO.2004.01.178","article-title":"Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer","volume":"22","author":"Fried","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0070","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1200\/JCO.2005.05.3181","article-title":"Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis","volume":"24","author":"Spiro","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0075","doi-asserted-by":"crossref","first-page":"e400S","DOI":"10.1378\/chest.12-2363","article-title":"Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Jett","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ygyno.2016.09.011_bb0080","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<712::AID-CNCR12>3.0.CO;2-V","article-title":"Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2016.09.011_bb0085","doi-asserted-by":"crossref","first-page":"780","DOI":"10.6004\/jnccn.2013.0100","article-title":"Systemic therapy for small cell lung cancer","volume":"11","author":"Levy","year":"2013","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0090","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/JTO.0b013e31829f6b03","article-title":"Should patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation?","volume":"8","author":"Naidoo","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ygyno.2016.09.011_bb0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2013.10.015","article-title":"Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study","volume":"132","author":"Zaid","year":"2014","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816314093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816314093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T13:59:05Z","timestamp":1568383145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816314093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0090825816314093"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.09.011","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of recurrence and survival in neuroendocrine cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}